| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.39▲ | 0.39▲ | 0.39▲ | 0.39▲ | 0.38▲ |
| MA10 | 0.38▲ | 0.38▲ | 0.38▲ | 0.38▲ | 0.39▲ |
| MA20 | 0.37▲ | 0.37▲ | 0.37▲ | 0.37▲ | 0.58▼ |
| MA50 | 0.37▲ | 0.37▲ | 0.37▲ | 0.40▼ | 1.14▼ |
| MA100 | 0.37▲ | 0.37▲ | 0.38▲ | 0.62▼ | 1.87▼ |
| MA200 | 0.38▲ | 0.39▲ | 0.40▼ | 0.98▼ | 7.23▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.003▲ | 0.003▲ | 0.006▲ | 0.025▲ |
| RSI | 64.939▲ | 64.847▲ | 64.066▲ | 52.642▲ | 37.597▼ |
| STOCH | 88.443▲ | 88.609▲ | 88.609▲ | 70.182 | 16.972▼ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -14.980▲ | -86.753▼ |
| CCI | 94.771 | 93.905 | 97.494 | 120.775▲ | -34.406 |
| CDL | $SNGX Doji Candlestick Pattern Detected | Set Alert |
|
Friday, August 07, 2026 04:30 AM
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
|
|
Monday, April 06, 2026 12:45 PM
Soligenix, Inc. (NASDAQ: SNGX) is currently conducting the Phase 3 FLASH2 Trial of HyBryte™ (SGX301 or synthetic hypericin) in the treatment of cutaneous T cell lymphoma (CTCL). As of the latest ...
|
|
Soligenix (NASDAQ: SNGX) Highlights Phase 3 CTCL Progress and Orphan Drug Milestones in 2025 Results
Tuesday, March 31, 2026 05:00 PM
Soligenix (NASDAQ:SNGX) reported 2025 results highlighting progress across its rare disease pipeline, including advancing its Phase 3 FLASH2 trial of HyBryte(TM) for cutaneous T-cell lymphoma with ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/08/26 | 0.3926 | 0.3926 | 0.3926 | 0.3926 | 72,052 |
| 11/08/26 | 0.3848 | 0.3921 | 0.3775 | 0.3865 | 95,092 |
| 10/08/26 | 0.3995 | 0.40 | 0.3775 | 0.3775 | 136,194 |
| 07/08/26 | 0.38 | 0.3966 | 0.3785 | 0.3921 | 129,799 |
| 06/08/26 | 0.3774 | 0.3936 | 0.3774 | 0.3788 | 128,912 |
| 05/08/26 | 0.3977 | 0.3977 | 0.377 | 0.3829 | 99,349 |
| 04/08/26 | 0.3774 | 0.3827 | 0.377 | 0.377 | 245,081 |
| 03/08/26 | 0.3797 | 0.3854 | 0.368 | 0.3775 | 197,072 |
| 31/07/26 | 0.3736 | 0.395 | 0.3631 | 0.3739 | 321,655 |
| 30/07/26 | 0.37 | 0.376 | 0.3548 | 0.375 | 238,802 |
|
|
||||
|
|
||||
|
|